Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Asthma Drives Oscillating Positive Expiratory Pressure (OPEP) Devices Market

According to our latest study on "Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 - COVID-19 Impact Analysis - by Product, Indication, Distribution Channel, and Geography," the market is expected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The key factors driving the market growth include the prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and advancements in medical technologies.

The incidence of COPD and cystic fibrosis is rising across the world. According to the World Health Organization (WHO), COPD exacerbations are critical events. COPD-related disability and mortality propel the demand for OPEP devices. According to the Center for Disease Control and Prevention (CDC), ~9 million adults were diagnosed with chronic bronchitis in 2018. Also, asthma is becoming common among people of all ages, genders, and races. According to CDC, ~300 million people worldwide suffer from asthma, with the expected addition of 100 million by 2025. The prevalence, severity, and mortality of asthma vary dramatically across the US. Asthma affects more than 25 million people in the US, which equates to 7.7% of adults and 8.4% of children. According to the 2018 Global Asthma Report about Auckland, New Zealand, asthma ranks 16th among the largest causes of disability and 28th among the greatest sources of disease burden, as assessed by disability-adjusted life years. It is common in high-income countries, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D- R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; and Mercury Medica are among the leading companies operating in the oscillating positive expiratory pressure (OPEP) devices market.

Based on product, the oscillating positive expiratory pressure (OPEP) devices market is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. Based on indication, the market is segmented into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. The oscillating positive expiratory pressure (OPEP) devices market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By geography, the oscillating positive expiratory pressure (OPEP) devices market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com